The Russian Direct Investment Fund (RDIF) applied for registration of the Sputnik V vaccine in the European Union on January 29, 2021, and scientific consultations with the European Medicines Agency (EMA) were held on January 19, the fund’s representative told reporters.
"RDIF submitted an application to EMA to participate in a scientific consultation on the Sputnik V vaccine on October 22, 2020. Representatives of the fund, vaccine developers, and EMA representatives held the scientific consultation on January 19," TASS cited the statement as saying.
"RDIF applied for registration of the Sputnik V vaccine in the European Union on January 29, 2021, and launched the process of submitting information to the EMA through a rolling review procedure," the fund said.
